Randall H Gholson
Examiner (ID: 17336, Phone: (571)272-1011 , Office: P/2918 )
Most Active Art Unit | 2918 |
Art Unit(s) | 2915, 2918 |
Total Applications | 3041 |
Issued Applications | 3007 |
Pending Applications | 0 |
Abandoned Applications | 34 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 3853250
[patent_doc_number] => 05767260
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-16
[patent_title] => 'Antigen-binding fusion proteins'
[patent_app_type] => 1
[patent_app_number] => 8/515903
[patent_app_country] => US
[patent_app_date] => 1995-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 22
[patent_no_of_words] => 11284
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/767/05767260.pdf
[firstpage_image] =>[orig_patent_app_number] => 515903
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/515903 | Antigen-binding fusion proteins | Aug 15, 1995 | Issued |
08/476991 | MONOSPECIFIC ANTIBODIES AND METHODS USING THEM | Jun 6, 1995 | Abandoned |
Array
(
[id] => 3888470
[patent_doc_number] => 05777078
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-07
[patent_title] => 'Triggered pore-forming agents'
[patent_app_type] => 1
[patent_app_number] => 8/478913
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 30
[patent_no_of_words] => 15440
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/777/05777078.pdf
[firstpage_image] =>[orig_patent_app_number] => 478913
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/478913 | Triggered pore-forming agents | Jun 6, 1995 | Issued |
Array
(
[id] => 3725154
[patent_doc_number] => 05651970
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-29
[patent_title] => 'Method for inhibiting disease associated with the human immunodeficiency virus through the use of monoclonal antibodies directed against anti-self cytotoxic T-lymphocytes or their lytics'
[patent_app_type] => 1
[patent_app_number] => 8/483745
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2916
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/651/05651970.pdf
[firstpage_image] =>[orig_patent_app_number] => 483745
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/483745 | Method for inhibiting disease associated with the human immunodeficiency virus through the use of monoclonal antibodies directed against anti-self cytotoxic T-lymphocytes or their lytics | Jun 6, 1995 | Issued |
Array
(
[id] => 3842822
[patent_doc_number] => 05766590
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-16
[patent_title] => 'Therapeutic methods and pharmaceutical compositions'
[patent_app_type] => 1
[patent_app_number] => 8/483184
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11142
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/766/05766590.pdf
[firstpage_image] =>[orig_patent_app_number] => 483184
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/483184 | Therapeutic methods and pharmaceutical compositions | Jun 6, 1995 | Issued |
Array
(
[id] => 3621559
[patent_doc_number] => 05620689
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-15
[patent_title] => 'Liposomes for treatment of B-cell and T-cell disorders'
[patent_app_type] => 1
[patent_app_number] => 8/475050
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 47
[patent_no_of_words] => 13545
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/620/05620689.pdf
[firstpage_image] =>[orig_patent_app_number] => 475050
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/475050 | Liposomes for treatment of B-cell and T-cell disorders | Jun 6, 1995 | Issued |
Array
(
[id] => 3994729
[patent_doc_number] => 05892020
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-06
[patent_title] => 'Multivalent single chain antibodies'
[patent_app_type] => 1
[patent_app_number] => 8/481006
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 24
[patent_no_of_words] => 9973
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/892/05892020.pdf
[firstpage_image] =>[orig_patent_app_number] => 481006
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/481006 | Multivalent single chain antibodies | Jun 6, 1995 | Issued |
Array
(
[id] => 3623261
[patent_doc_number] => 05688927
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-18
[patent_title] => 'Macrophage derived chemokine'
[patent_app_type] => 1
[patent_app_number] => 8/480449
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11813
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/688/05688927.pdf
[firstpage_image] =>[orig_patent_app_number] => 480449
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/480449 | Macrophage derived chemokine | Jun 6, 1995 | Issued |
Array
(
[id] => 3781490
[patent_doc_number] => 05736139
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-07
[patent_title] => 'Treatment of Clostridium difficile induced disease'
[patent_app_type] => 1
[patent_app_number] => 8/480604
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 55
[patent_no_of_words] => 110331
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/736/05736139.pdf
[firstpage_image] =>[orig_patent_app_number] => 480604
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/480604 | Treatment of Clostridium difficile induced disease | Jun 6, 1995 | Issued |
Array
(
[id] => 3618982
[patent_doc_number] => 05601821
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-11
[patent_title] => 'Immunoactive peptides and antibodies and their use in anti-allergy treatment'
[patent_app_type] => 1
[patent_app_number] => 8/480505
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 9505
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/601/05601821.pdf
[firstpage_image] =>[orig_patent_app_number] => 480505
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/480505 | Immunoactive peptides and antibodies and their use in anti-allergy treatment | Jun 6, 1995 | Issued |
Array
(
[id] => 3831604
[patent_doc_number] => 05846535
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-08
[patent_title] => 'Methods for reducing tumor cell growth by using antibodies with broad tumor reactivity and limited normal tissue reactivity'
[patent_app_type] => 1
[patent_app_number] => 8/467959
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4763
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/846/05846535.pdf
[firstpage_image] =>[orig_patent_app_number] => 467959
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/467959 | Methods for reducing tumor cell growth by using antibodies with broad tumor reactivity and limited normal tissue reactivity | Jun 5, 1995 | Issued |
Array
(
[id] => 3774630
[patent_doc_number] => 05756683
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-26
[patent_title] => 'Immunological detection method'
[patent_app_type] => 1
[patent_app_number] => 8/470529
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15468
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/756/05756683.pdf
[firstpage_image] =>[orig_patent_app_number] => 470529
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/470529 | Immunological detection method | Jun 5, 1995 | Issued |
Array
(
[id] => 3630819
[patent_doc_number] => 05686583
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-11
[patent_title] => 'Specific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapy'
[patent_app_type] => 1
[patent_app_number] => 8/467393
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 25
[patent_no_of_words] => 4405
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/686/05686583.pdf
[firstpage_image] =>[orig_patent_app_number] => 467393
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/467393 | Specific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapy | Jun 5, 1995 | Issued |
Array
(
[id] => 3655731
[patent_doc_number] => 05658763
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-19
[patent_title] => 'Methods and compositions for high protein production from non-native DNA'
[patent_app_type] => 1
[patent_app_number] => 8/463675
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13010
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 247
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/658/05658763.pdf
[firstpage_image] =>[orig_patent_app_number] => 463675
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/463675 | Methods and compositions for high protein production from non-native DNA | Jun 4, 1995 | Issued |
Array
(
[id] => 3861077
[patent_doc_number] => 05792838
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-11
[patent_title] => 'Method for stabilizing immunoglobulin compositions'
[patent_app_type] => 1
[patent_app_number] => 8/465319
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5099
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/792/05792838.pdf
[firstpage_image] =>[orig_patent_app_number] => 465319
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/465319 | Method for stabilizing immunoglobulin compositions | Jun 4, 1995 | Issued |
Array
(
[id] => 3733992
[patent_doc_number] => 05753204
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-19
[patent_title] => 'Biosynthetic binding proteins for immunotargeting'
[patent_app_type] => 1
[patent_app_number] => 8/461838
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 15385
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 230
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/753/05753204.pdf
[firstpage_image] =>[orig_patent_app_number] => 461838
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/461838 | Biosynthetic binding proteins for immunotargeting | Jun 4, 1995 | Issued |
Array
(
[id] => 3661522
[patent_doc_number] => 05624896
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-29
[patent_title] => 'Clearing agents useful in pretargeting methods'
[patent_app_type] => 1
[patent_app_number] => 8/462765
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 34573
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/624/05624896.pdf
[firstpage_image] =>[orig_patent_app_number] => 462765
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/462765 | Clearing agents useful in pretargeting methods | Jun 4, 1995 | Issued |
Array
(
[id] => 3874744
[patent_doc_number] => 05747337
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-05
[patent_title] => 'Factor VIII coagulant polypeptides and monoclonal antibodies to them'
[patent_app_type] => 1
[patent_app_number] => 8/462114
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9021
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/747/05747337.pdf
[firstpage_image] =>[orig_patent_app_number] => 462114
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/462114 | Factor VIII coagulant polypeptides and monoclonal antibodies to them | Jun 4, 1995 | Issued |
08/459206 | VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS | Jun 1, 1995 | Abandoned |
Array
(
[id] => 3850403
[patent_doc_number] => 05719267
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-17
[patent_title] => 'Clostridial toxin disease therapy'
[patent_app_type] => 1
[patent_app_number] => 8/457890
[patent_app_country] => US
[patent_app_date] => 1995-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10968
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/719/05719267.pdf
[firstpage_image] =>[orig_patent_app_number] => 457890
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/457890 | Clostridial toxin disease therapy | May 31, 1995 | Issued |